Health Care/Hospital
Significant Weight Loss and Multiple Metabolic Benefits: Phase 1b Study Results of IBI362 in Chinese Participants with Overweight or Obesity Published in EClinicalMedicine by the Lancet
SAN FRANCISCO and SUZHOU, China, Aug. 18, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...
2021-08-18 08:00
5000
Red ginseng of Korea Ginseng Corp. (KGC), the representative food of K-immunity, occupies about 70% of the Korean market
* KGC leading the buzzword, K-immunity like K-pop * Global exports beyond the domestic market in the pandemic SEOUL, South Korea ,Aug. 18, 2021 /PRNewswire/ -- The Korea's no. 1 red ginseng brand is CheongKwanJang of KGC, accounting for approximately 70% of the entire red ginseng market in the...
2021-08-18 08:00
5872
Red ginseng of Korea Ginseng Corp. (KGC), the representative food of K-immunity, occupies about 70% of the Korean market
* KGC leading the buzzword, K-immunity like K-pop * Global exports beyond the domestic market in the pandemic SEOUL, South Korea ,Aug. 18, 2021 /PRNewswire/ -- The Korea's no. 1 red ginseng brand is CheongKwanJang of KGC, accounting for approximately 70% of the entire red ginseng market in the...
2021-08-18 08:00
3572
PT Anugerah Pharmindo Lestari (APL) Won 'Community Initiative' Award and 'Outstanding Leader in Asia' Title for Its President Director at the Asia Corporate Excellence & Sustainability Awards 2021
JAKARTA, Indonesia, Aug. 17, 2021 /PRNewswire/ -- PT Anugerah Pharmindo Lestari (APL), a member of Zuellig Pharma, a leading healthcare services company in Indonesia, has been awarded with the 'Community Initiative' and 'Outstanding Leader inAsia' for APL's President Director, Christophe Piganiol,...
2021-08-17 22:02
3720
Bon Natural Life Limited Announces Record First Half-Year Revenue and Net Income
-1H-2021 Revenue increases by 63.6% to $11.7 million- XI'AN, China, Aug. 17, 2021 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced its half-y...
2021-08-17 20:00
3730
MediTrust Health Raises Over RMB2 Billion in Series C Financing Successfully: ESG Drives Value Creation
HONG KONG, Aug. 17, 2021 /PRNewswire/ -- Shanghai MediTrust Health Technology Co., Ltd. (hereinafter referred to as "MediTrust"), a leading innovative healthcare services platform inChina, announced a successful capital raising of overRMB2 billion (approximately US$308 million) in a Series C fina...
2021-08-17 19:47
2731
Innoforce Pharmaceuticals Opens Analytical Development and Process Development Facility in Hangzhou, China
HANGZHOU, China and ROCKVILLE, Md., Aug. 17, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("Innoforce"), a biopharmaceutical innovation and partnership company, today announces that it has opened a new Advanced Cell and Gene Therapy Development Facility inHangzhou, China. Analytical development...
2021-08-17 19:00
2930
SINOMED announces the first commercial implantation and European launch of the HT Supreme Drug Eluting Stent
TIANJIN, China, Aug. 17, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, announced the first commercial implantation of the HT Supreme® Drug-Eluting Stent (DES) at University Hospital Galway in partnership with theNational University of Ireland Galway (NUI Galway), m...
2021-08-17 18:00
3073
MILVIK Launches COVID-19 Insurance and Telemedicine Bundle in Bangladesh
DHAKA, Bangladesh, Aug. 17, 2021 /PRNewswire/ -- Global healthcare and
insurtech providerMILVIK
2021-08-17 10:00
3908
Under the Patronage of His Highness Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Abu Dhabi Early Childhood Authority's WED Movement Engages Global Experts to Drive Innovation, Excellence in Early Childhood Development
ABU DHABI, UAE, Aug. 17, 2021 /PRNewswire/ -- Abu Dhabi's World Early Childhood Development Movement (WED Movement) has launched a new initiative bringing together global experts to develop innovative and actionable solutions advancing Abu Dhabi's vision to be a leader in Early Childhood Developme...
2021-08-17 00:51
4286
Tikomed's ILB® attenuates clinical symptoms and serum biomarkers of oxidative/nitrosative stress and mitochondrial dysfunction in ALS patients, data published by the Journal of Personalized Medicine
VIKEN, Sweden, Aug. 16, 2021 /PRNewswire/ -- New study results for Tikomed's platform lead drug candidate ILB® in the treatment of patients with amyotrophic lateral sclerosis (ALS), have now been published in the Journal of Personalized Medicine. The data revealed a significant normalization of t...
2021-08-16 22:32
1903
InferVision AI Assists the European Commission Monitoring COVID-19 Variants
WIESBADEN, Germany, Aug. 16, 2021 /PRNewswire/ -- InferVision AI has been selected to help monitor COVID-19 variants across the European Union. Faced with this challenge, the European Commission decided to increase their investment in the adoption of AI tools from InferVision. InferVision's AI to...
2021-08-16 21:51
4861
Ascletis' Partner Sagimet Dosed First Patient in FASCINATE-2 Phase IIb Trial in NASH Patients with Moderate to Advanced Fibrosis
HANGZHOU and SHAOXING, China, Aug. 16, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) today announces that its partner Sagimet Biosciences dosed the first patient in its FASCINATE-2 Phase IIb clinical trial for non-alcoholic steatohepatitis (NASH). FASCINATE-2 is a randomized, double-blin...
2021-08-16 21:30
4425
BioAgilytix to Purchase Australia-based 360biolabs®
Highly complementary transaction will strengthen company's ability to support bioanalytical services across all stages, development capabilities and geographies DURHAM, N.C., Aug. 16, 2021 /PRNewswire/ -- BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused ...
2021-08-16 18:00
4450
Ping An Supports COVID-19 Control Efforts in Philippines
HONG KONG and SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- COVID-19 diagnosis and treatment inthe Philippines is being supported by Ping An's groundbreaking artificial intelligence-driven AskBob Clinical Decision Support System, announced Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Pin...
2021-08-16 17:22
10772
Introducing ProXmask(TM): Antiviral Face Mask as Better Alternative to Double-Masking and Capable of Inactivate SARS-CoV-2
KUALA LUMPUR, Malaysia, Aug. 16, 2021 /PRNewswire/ -- ProXmask™ is the first antiviral face mask mass-produced in theAsia Pacific by Prolexus Group. The antiviral face mask created by Prolexus Group is a remarkable example of conventional OEM (original equipment manufacturer) for globally renowne...
2021-08-16 15:21
3872
Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market
SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Sino Biological (SZSE: 301047) onAugust 16th listed on Shenzhen's ChiNext Market. The issue price isCNY 292.92 per share. The stock opened at CNY 599.9, up 104.8%, representing a market cap of CNY 40.79 billion. Q...
2021-08-16 14:14
3726
Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 /PRNewswire/ -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the conditional U.S. Food and Drug Administration ("FDA") approval of its Investigational Device Exem...
2021-08-16 14:00
2850
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange
BEIJING, Aug. 16, 2021 /PRNewswire/ -- Sino Biological, Inc. ("Sino Biological" or the "Company"), a biotechnology company which provides biological research reagents and related technical contract research services, announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext...
2021-08-16 13:12
6523
Innovent Announces Sintilimab in Combination with Chemotherapy Meets the Primary Endpoint of Overall Survival in the Phase 3 ORIENT-16 Study for the First-Line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
SAN FRANCISCO and SUZHOU, China, Aug. 16, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
2021-08-16 08:00
7128
Week's Top Stories
Most Reposted
TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia
[Picked up by 316 media titles]
2026-06-08 10:16
DayOne Secures Over 1GW Renewable Energy in Malaysia in Landmark TNB Partnership
[Picked up by 303 media titles]
2026-06-04 23:55
Amartha Initiates Coalition to Advance Financial Health for Grassroots Communities in Indonesia
[Picked up by 296 media titles]
2026-06-05 19:08
DayOne Data Centers Announces Final Closing of its Series C Equity Financing at US$4.5 Billion
[Picked up by 294 media titles]
2026-06-05 15:00Omni HR Launches Mino, the First AI Agent Built on Unified APAC HR Data
[Picked up by 284 media titles]
2026-06-08 09:00
Most Read
YY Group (NASDAQ: YYGH) Wins Prestigious HAPA Solutions Excellence Award, Validating Enterprise AI Marketplace Adoption in Southeast Asia
2026-06-05 19:37
8969
Dreame ranked No.1 in Global Robot Vacuum Sales & Revenue, according to International Data Corporation (IDC)
2026-06-05 21:05
8186
Tuniu Announces Unaudited First Quarter 2026 Financial Results
2026-06-05 18:00
7797
